Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes.

Abstract:

:Lenalidomide and azacitidine are active in MDS patients, and may complement each other by targeting the bone marrow microenvironment and the malignant clone. A recent Phase I trial testing the lenalidomide and azacitidine combination yielded encouraging results; however, lenalidomide’s contribution was unclear. In this study, 18 higher-risk MDS patients were treated with the combination for seven cycles, after which lenalidomide was discontinued in eight patients who achieved a complete response, with azacitidine monotherapy continuing until disease progression. We report on three patients who relapsed on monotherapy with excess blasts at 12, 19, and 24 months, in whom lenalidomide was then resumed in combination with azacitidine. Each patient, one with normal cytogenetics at relapse; one with a 18 abnormality; and one with del(4q25), recaptured a complete response that was sustained for 5, 7, and 7+ months. We conclude that the addition of lenalidomide to azacitidine provides additional clinical benefit over azacitidine monotherapy.

journal_name

Am J Hematol

authors

Sekeres MA,O'Keefe C,List AF,Paulic K,Afable M 2nd,Englehaupt R,Maciejewski JP

doi

10.1002/ajh.21891

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

102-3

issue

1

eissn

0361-8609

issn

1096-8652

journal_volume

86

pub_type

杂志文章,多中心研究
  • Assessment of alkaline phosphatase on the surface membrane of neutrophils by immunofluorescence.

    abstract::Expression of alkaline phosphatase (ALP) on the surface membrane of neutrophils (mNAP) was studied by immunofluorescence using an anti-ALP monoclonal antibody. Fluorescent intensity distribution of mNAP was analyzed using FACS (fluorescence-activated cell sorter). The mean fluorescent intensity (MFI) of the mNAP in th...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199901)60:1<12::aid-ajh3>3

    authors: Shibano M,Machii T,Nishimori Y,Nakamoto I,Ueda E,Masuhara K,Kitani T

    更新日期:1999-01-01 00:00:00

  • Clinical presentation of severe anemia in pediatric patients with sickle cell anemia seen in Enugu, Nigeria.

    abstract::Anemia is a major cause of morbidity and mortality among patients with sickle cell anemia. In this study, 108 episodes of severe anemia were prospectively evaluated in 108 patients with hemoglobin SS disease attending the pediatric sickle cell clinic of the University of Nigeria Teaching Hospital, Enugu, Nigeria. Youn...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10285

    authors: Juwah AI,Nlemadim A,Kaine W

    更新日期:2003-03-01 00:00:00

  • Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature.

    abstract::Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome (HUS) is a recently defined clinical entity. In this paper we have attempted to characterize the natural history and laboratory abnormalities typical of quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome in nine patie...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.2830470407

    authors: Gottschall JL,Neahring B,McFarland JG,Wu GG,Weitekamp LA,Aster RH

    更新日期:1994-12-01 00:00:00

  • Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.

    abstract::Acquired α-thalassemia myelodysplastic syndrome (MDS) (ATMDS) is an acquired syndrome characterized by a somatic point mutation or splicing defect in the ATRX gene in patients with myeloid disorders, primarily MDS. In a large MDS patient series, the incidence of ATMDS was below 0.5%. But no large series has yet assess...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24073

    authors: Herbaux C,Duployez N,Badens C,Poret N,Gardin C,Decamp M,Eclache V,Daliphard S,Murati A,Cony-Makhoul P,Cheze S,Beve B,Lacoste C,Prebet T,Hunault-Berger M,Maloisel F,Renneville A,Figeac M,Stamatoullas-Bastard A,Bastar

    更新日期:2015-08-01 00:00:00

  • Consensus statement on iron overload in myelodysplastic syndromes.

    abstract::In May 2005 at the 8th International Symposium on Myelodysplastic Syndromes (MDS), a consensus meeting was held on iron overload in MDS (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25). The recommendations of the 2005 consensus meeting were discussed in the context of currently available evidence at the 9th Internati...

    journal_title:American journal of hematology

    pub_type: 杂志文章,实务指引

    doi:10.1002/ajh.21269

    authors: Bennett JM,MDS Foundation's Working Group on Transfusional Iron Overload.

    更新日期:2008-11-01 00:00:00

  • Biosimilar epoetins and other "follow-on" biologics: update on the European experiences.

    abstract::After the patents of biopharmaceuticals have expired, based on specific regulatory approval pathways copied products ("biosimilars" or "follow-on biologics") have been launched in the EU. This article summarizes experiences with hematopoietic medicines, namely the epoetins (two biosimilars traded under five different ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.21805

    authors: Jelkmann W

    更新日期:2010-10-01 00:00:00

  • Reactivation and dissemination of blastomycosis complicating Hodgkin's disease: a case report and review of the literature.

    abstract::Patients presenting with Hodgkin's disease (HD) may show lung involvement characterized by contiguous spread from ipsilateral hilar lymph nodes. Lung consolidation or noncontiguous pulmonary involvement makes an alternative diagnosis more likely. This report describes a patient with HD in whom concurrent pulmonary bla...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.2830430211

    authors: Winquist EW,Walmsley SL,Berinstein NL

    更新日期:1993-06-01 00:00:00

  • Coincidental polycythemia vera and multiple myeloma: case report and review.

    abstract::Polycythemia vera (PCV) and multiple myeloma are both clonal disorders of hematopoietic stem cells. The simultaneous occurrence of these diseases in an individual patient is rare. A case of synchronous PCV and smoldering myeloma is presented and the literature is reviewed. The issues of clinical importance in this unu...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.2830440311

    authors: Fink L,Bauer F,Perry JJ

    更新日期:1993-11-01 00:00:00

  • Abnormal erythrocyte metabolism in hepatic disease: effect of NADP repletion.

    abstract::Erythrocytes from ten patients with severe liver disease displayed low methylene blue-stimulated hexose monophosphate (HMP) shunt activity and glucose recycling despite elevated total glucose consumption when compared to controls. Heinz body formation was increased and reduced glutathione concentration significantly d...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830060403

    authors: Smith JR,Kay NE,Gottlieb AJ,Oski FA

    更新日期:1979-01-01 00:00:00

  • Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

    abstract::In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%. This risk has been estimated to be 1-5.9% with hydroxyurea (HU) therapy. When compared with historical controls, the risk with use of HU does not appear to be statist...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3

    authors: Nand S,Stock W,Godwin J,Fisher SG

    更新日期:1996-05-01 00:00:00

  • CAR T-cells merge into the fast lane of cancer care.

    abstract::Chimeric antigen receptors (CARs) can be introduced into T-cells redirecting them to target specific tumor antigens. CAR-modified T cells targeting CD19 have shown remarkable activity against CD19+ malignancies including B cell acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymph...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.24238

    authors: Frey NV,Porter DL

    更新日期:2016-01-01 00:00:00

  • New alpha 2 globin chain variant with low oxygen affinity affecting the N-terminal residue and leading to N-acetylation [Hb Lyon-Bron alpha 1(NA1)Val --> Ac-Ala].

    abstract::Hemoglobin Lyon-Bron was found in two members of a family of German ascent presenting with a moderate normocytic anemia. In this alpha 2 globin variant, the N-terminal valine of the chain was replaced by an alanine. Electrospray mass spectrometry of the alpha chain showed that, as normally, the initiator methionine wa...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10051

    authors: Lacan P,Souillet G,Aubry M,Promé D,Richelme-David S,Kister J,Wajcman H,Francina A

    更新日期:2002-03-01 00:00:00

  • Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.

    abstract::A preclinical study demonstrated anti-proliferative and apoptotic effect of propranolol on multiple myeloma (MM) cell. Clinical studies suggested that beta-blocker (BB) might impact the prognosis of breast, prostate, colorectal, ovarian, lung, and skin cancer. This retrospective study evaluated the effect of BB in MM ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24582

    authors: Hwa YL,Shi Q,Kumar SK,Lacy MQ,Gertz MA,Kapoor P,Buadi FK,Leung N,Dingli D,Go RS,Hayman SR,Gonsalves WI,Russell S,Lust JA,Lin Y,Rajkumar SV,Dispenzieri A

    更新日期:2017-01-01 00:00:00

  • Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.

    abstract::Children with sickle cell anemia (SCA) and a primary overt stroke are at high risk of recurrent (secondary) stroke. Chronic transfusion therapy dramatically reduces but does not eliminate this high risk, and inevitably results in transfusion-related hemosiderosis. We previously reported the use of hydroxyurea/phleboto...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21986

    authors: Greenway A,Ware RE,Thornburg CD

    更新日期:2011-04-01 00:00:00

  • Synthesis of the minor fetal hemoglobin Fic in colonies of erythropoietic precursors isolated from human umbilical cord blood.

    abstract::The biosynthesis of the minor hemoglobin FIc, which contains acetylated gamma chains, and the major hemoglobin Fo was studied during erythroid cell differentiation and maturation in cultures of erythroid precursors isolated from five human umbilical cord blood samples. A gradual decrease in the synthesis of Hb FIc was...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830120302

    authors: Abraham EC,Reese AL,Stallings M,Abraham A,Garbutt GJ,Huisman TH

    更新日期:1982-05-01 00:00:00

  • Prevalence of pulmonary hypertension in hereditary spherocytosis.

    abstract::Vascular complications, including pulmonary hypertension (PH), have been reported to occur following splenectomy for various disorders,including hereditary spherocytosis (HS). We performed a prospective cross-sectional study of 36 adults with HS (78% with prior splenectomy)utilizing echocardiography to estimate tricus...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.22182

    authors: Crary SE,Ramaciotti C,Buchanan GR

    更新日期:2011-12-01 00:00:00

  • Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy.

    abstract::We describe 3 episodes of microangiopathic hemolytic anemia (MAHA) in 2 solid organ recipients under FK506 (tacrolimus) therapy. In both cases, discontinuation of FK506 and treatment with plasma exchange, fresh frozen plasma replacement, corticosteroids, aspirin, and dipyridamole led to resolution of MAHA. In one pati...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(SICI)1096-8652(199608)52:4<310::AID-AJH11

    authors: Mach-Pascual S,Samii K,Beris P

    更新日期:1996-08-01 00:00:00

  • Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome.

    abstract::The occurrence of factor VIII inhibitors in non-hemophilic patients is a rare event with a potentially lethal outcome. Despite its infrequent occurrence, the association of this inhibitor with multiple autoimmune diseases is well recognized. We report the case of a patient with the recently described autoimmune lympho...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/1096-8652(200007)64:3<214::aid-ajh14>3.0.c

    authors: Fang BS,Sneller MC,Straus SE,Frenkel L,Dale JK,Rick ME

    更新日期:2000-07-01 00:00:00

  • Hemostatic molecular markers in nephrotic syndrome.

    abstract::Quantitative changes of hemostatic molecular markers were studied in patients with nephrotic syndrome. The plasma levels of fibrinopeptide A (FPA), thrombin-antithrombin III complex (TAT), products of thrombin activation, and fragment F1 + 2 (F1 + 2), a product of prothrombin activation, were measured by enzyme immuno...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830440411

    authors: Chen TY,Huang CC,Tsao CJ

    更新日期:1993-12-01 00:00:00

  • Outcomes and management strategies for graft failure after umbilical cord blood transplantation.

    abstract::Graft failure is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (HSCT). Graft failure is more prevalent after umbilical cord blood transplantation (UCBT) compared with conventional adult stem cell sources. We identified 21 consecutive patients who experienced graft failure aft...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23845

    authors: Singh H,Nikiforow S,Li S,Ballen KK,Spitzer TR,Soiffer R,Antin JH,Cutler C,Chen YB

    更新日期:2014-12-01 00:00:00

  • Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes.

    abstract::The underlying mechanisms of reactive macrophage activation syndromes (rMAS) are not understood in detail, and there is no specific treatment. This observational study was prompted by intravenous immunoglobulin (IVIG), dramatically halting two distinct rMAS episodes in the same patient. We evaluated the potential bene...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.1141

    authors: Emmenegger U,Frey U,Reimers A,Fux C,Semela D,Cottagnoud P,Spaeth PJ,Neftel KA

    更新日期:2001-09-01 00:00:00

  • Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.

    abstract::Unprecedented advances in our understanding of the pathobiology, prognostication, and therapeutic options in mantle cell lymphoma (MCL) have taken place in the last few years. Heterogeneity in the clinical course of MCL-indolent vs aggressive-is further delineated by a correlation with the mutational status of the var...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.25487

    authors: Jain P,Wang M

    更新日期:2019-06-01 00:00:00

  • Inpatient management of sickle cell pain: a 'snapshot' of current practice.

    abstract::The Sickle Cell Disease Clinical Research Network (SCDCRN) designed the PROACTIVE Feasibility Study (ClinicalTrials.gov NCT00951808) to determine whether elevated serum levels of secretory phospholipase A2 (sPLA2) during hospitalization for pain would permit preemptive therapy of sickle cell acute chest syndrome (ACS)...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.22265

    authors: Miller ST,Kim HY,Weiner D,Wager CG,Gallagher D,Styles L,Dampier CD,Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

    更新日期:2012-03-01 00:00:00

  • Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients.

    abstract::Although karyotypic abnormalities are well documented in B-cell chronic lymphocytic leukemia (B-CLL), few sequential cytogenetic studies have been done. In this study, peripheral blood lymphocytes from fifty-one patients with B-CLL were sequentially karyotyped over a mean interval of 13.8 months (range, one to 51 mont...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199811)59:3<223::aid-ajh7>

    authors: Finn WG,Kay NE,Kroft SH,Church S,Peterson LC

    更新日期:1998-11-01 00:00:00

  • Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry.

    abstract::Single agents have demonstrated activity in relapsed and refractory (R/R) peripheral T-cell lymphoma (PTCL). Their benefit relative to combination chemotherapy remains undefined. Patients with histologically confirmed PTCL were enrolled in the Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment (C...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.25463

    authors: Stuver RN,Khan N,Schwartz M,Acosta M,Federico M,Gisselbrecht C,Horwitz SM,Lansigan F,Pinter-Brown LC,Pro B,Shustov AR,Foss FM,Jain S

    更新日期:2019-06-01 00:00:00

  • beta-Thalassemia arising as a new mutation in an American child.

    abstract::A 6-year-old child of northern European ancestry was found to have microcytic, hypochromic anemia with an elevated level of hemoglobin A2 and an unbalanced pattern of globin chain synthesis characteristic of beta-thalassemia trait. Hematologic and globin synthesis studies of both parents yielded entirely normal result...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830040211

    authors: Nronha PA,Honig GR

    更新日期:1978-01-01 00:00:00

  • Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.

    abstract::Neutrophil elastase (NE) is a serine protease stored in the primary granules of neutrophils that proteolytically cleaves multiple cytokines and cell surface proteins on release from activated neutrophils. Recent reports of mutations in the gene encoding this enzyme in some patients with neutropenic syndromes prompted ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10434

    authors: Hunter MG,Druhan LJ,Massullo PR,Avalos BR

    更新日期:2003-11-01 00:00:00

  • Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.

    abstract::In patients with acute myeloid leukemia (AML), the presence of residual disease at day 14 after primary induction therapy warrants consideration of a second induction cycle. However, data to guide retreatment decisions in such patients are presently limited. Here, we retrospectively reviewed data from 176 patients wit...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24627

    authors: Griffin PT,Komrokji RS,Sweet K,Al Ali NH,Padron E,Kubal TE,List AF,Lancet JE

    更新日期:2017-03-01 00:00:00

  • Evidence that circulating immune complexes remove transfused platelets from the circulation.

    abstract::Fifteen recently diagnosed patients with acute leukemias admitted for induction chemotherapy were selected for study. When thrombocytopenic (venous platelet count less than 20 X 10(9)/l) these patients received prophylactic platelet transfusions. A total of 67 platelet transfusion therapies were administered and evalu...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830110305

    authors: Kutti J,Zaroulis CG,Safai-Kutti S,Dinsmore RE,Day NK,Good RA

    更新日期:1981-11-01 00:00:00

  • Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function.

    abstract::Alpha-hemoglobin stabilizing protein (AHSP) is a potential modifier of beta-thalassemia by virtue of its ability to detoxify excess free alpha-globin. However, examination of patients with beta-thalassemia from a few geographic regions failed to identify obvious AHSP mutations. We extended these studies by analyzing A...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21041

    authors: dos Santos CO,Zhou S,Secolin R,Wang X,Cunha AF,Higgs DR,Kwiatkowski JL,Thein SL,Gallagher PG,Costa FF,Weiss MJ

    更新日期:2008-02-01 00:00:00